Skip to main content
NCBI home page
Canadian Journal of Comparative Medicine logoLink to Canadian Journal of Comparative Medicine
. 1981 Jan;45(1):43–50.

Response of cows with lymphoma to the intradermal injection of tumor cell antigens and phytohemagglutinin.

R M Jacobs, V E Valli, B N Wilkie
PMCID: PMC1320119  PMID: 7272841

Abstract

Tumor cell-membrane antigens did not elicit specific intradermal reactions in cows with lymphoma and were therefore not effective in identifying animals with tumor. Sixty-two percent (8/13) of cows with lymphoma in the advanced stages of disease responded poorly to the intradermal injection of a nonspecific mitogen (PHA-M) and normal lymphoid cell extracts. This finding may explain the lack of response to the tumor cell extracts that some cows with lymphoma and indicates the presence of immune deficits in animals with lymphoma. Six of eight animals with tumor and poor cutaneous sensitivity had sera that inhibited the blastogenesis of normal lymphocytes. The presence of this inhibitory material is associated with the presence of tumor, not with bovine leukemia virus infection and partially accounts for the relative cutaneous anergy in cattle with lymphoma.

Full text

PDF
43

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin R. W., Price M. R., Robins R. A. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes. Nat New Biol. 1972 Aug 9;238(84):185–186. doi: 10.1038/newbio238185a0. [DOI] [PubMed] [Google Scholar]
  2. Blaese R. M., Weiden P., Oppenheim J. J., Waldmann T. A. Phytohemagglutinin as a skin test for the evaluation of cellular immune competence in man. J Lab Clin Med. 1973 Apr;81(4):538–548. [PubMed] [Google Scholar]
  3. Bluming A. Z., Ziegler J. L., Fass L., Herberman R. B. Delayed cutaneous sensitivity reactions to autologous Burkitt lymphoma protein extract. Results of a prospective two and a half year study. Clin Exp Immunol. 1971 Dec;9(6):713–719. [PMC free article] [PubMed] [Google Scholar]
  4. Bonforte R. J., Topilsky M., Siltzbach L. E., Glade P. R. Phytohemagglutinin skin test: a possible in vivo measure of cell-mediated immunity. J Pediatr. 1972 Oct;81(4):775–780. doi: 10.1016/s0022-3476(72)80101-x. [DOI] [PubMed] [Google Scholar]
  5. Char D. H., Hollinshead A., Cogan D. G., Ballintine E. J., Hogan M. J., Herberman R. B. Cutaneous delayed hypersensitivity reactions to soluble melanoma antigen in patients with ocular malignant melanoma. N Engl J Med. 1974 Aug 8;291(6):274–277. doi: 10.1056/NEJM197408082910603. [DOI] [PubMed] [Google Scholar]
  6. Char D. H., Lepourhiet B. G., Herberman R. B. Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia. Int J Cancer. 1973 Sep 15;12(2):409–419. doi: 10.1002/ijc.2910120212. [DOI] [PubMed] [Google Scholar]
  7. Currie G. A., Basham C. Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen. Br J Cancer. 1972 Dec;26(6):427–438. doi: 10.1038/bjc.1972.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davies D. A. Mouse histocompatibility isoantigens derived from normal and from tumour cells. Immunology. 1966 Aug;11(2):115–125. [PMC free article] [PubMed] [Google Scholar]
  9. Embleton M. J. Influence of cell-free tumour-associated antigen preparations on the development of immunity to chemically induced rat tumours. Int J Cancer. 1976 Nov 15;18(5):622–629. doi: 10.1002/ijc.2910180511. [DOI] [PubMed] [Google Scholar]
  10. Glasgow A. H., Nimberg R. B., Menzoian J. O., Saporoschetz I., Cooperband S. R., Schmid K., Mannick J. A. Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer. N Engl J Med. 1974 Dec 12;291(24):1263–1267. doi: 10.1056/NEJM197412122912401. [DOI] [PubMed] [Google Scholar]
  11. Hellström I., Sjögren H. O., Warner G., Hellström K. E. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int J Cancer. 1971 Mar 15;7(2):226–237. doi: 10.1002/ijc.2910070206. [DOI] [PubMed] [Google Scholar]
  12. Hollinshead A. C., McWright C. G., Alford TC GLEW D. H., Gold P., Herbeman R. B. Separation of skin reactive intestinal cancer antigen from the carcinoembryonic antigen of Gold. Science. 1972 Sep 8;177(4052):887–889. doi: 10.1126/science.177.4052.887. [DOI] [PubMed] [Google Scholar]
  13. Hollinshead A. C., Stewart T. H., Herberman R. B. Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells. J Natl Cancer Inst. 1974 Feb;52(2):327–338. doi: 10.1093/jnci/52.2.327. [DOI] [PubMed] [Google Scholar]
  14. Jacobs R. M., Valli V. E., Wilkie B. N. Inhibition of lymphocyte blastogenesis by sera from cows with lymphoma. Am J Vet Res. 1980 Mar;41(3):372–376. [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Levine P. H., Ho J. H., Nkrumah F., Periman P., Mourali N., Cannon G., Middleton M. B., Perkins I. V., Herberman R. Delayed hypersensitivity reactions of cancer patients to antigens on lymphoid cell lines. Int J Cancer. 1978 Oct 15;22(4):400–404. doi: 10.1002/ijc.2910220406. [DOI] [PubMed] [Google Scholar]
  17. MOWBRAY J. F. Effect of large doses of an alpha2-glycoprotein fraction on the survival of rat skin homografts. Transplantation. 1963 Jan;1:15–20. doi: 10.1097/00007890-196301010-00003. [DOI] [PubMed] [Google Scholar]
  18. Matthaeus W., Straub O. C. Das Serum-gamma-Globulinbild bei leukosekranken Rindern und Schafen. Zentralbl Veterinarmed B. 1975 Nov;22(9):758–763. [PubMed] [Google Scholar]
  19. Menzoian J. O., Glasgow A. H., Nimberg R. D., Cooperband S. R., Schmid K., Saporoschetz I., Mannick J. A. Regulation of T lymphocyte function by immunoregulatory alphaglobulin (IRA). J Immunol. 1974 Jul;113(1):266–273. [PubMed] [Google Scholar]
  20. Muscoplat C. C., Alhaji I., Johnson D. W., Pomeroy K. A., Olson J. M., Larson V. L., Stevens J. B., Sorensen D. K. Characteristics of lymphocyte responses to phytomitogens: comparison of responses of lymphocytes from normal and lymphocytotic cows. Am J Vet Res. 1974 Aug;35(8):1053–1055. [PubMed] [Google Scholar]
  21. Oren M. E., Herberman R. B. Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells. Clin Exp Immunol. 1971 Jul;9(1):45–56. [PMC free article] [PubMed] [Google Scholar]
  22. Trainin Z., Klopfer U. Immunofluorescent studies of lymph nodes and spleens of leukotic cattle for cells producing IgM and IgG. Cancer Res. 1971 Dec;31(12):1968–1970. [PubMed] [Google Scholar]
  23. Trainin Z., Ungar-Waron H., Meirom R., Barnea A., Sela M. IgG and IgM antibodies in normal and leukaemic cattle. J Comp Pathol. 1976 Oct;86(4):571–580. doi: 10.1016/0021-9975(76)90066-9. [DOI] [PubMed] [Google Scholar]
  24. Weese J. L., Herberman R. B., Hollinshead A. C., Cannon G. B., Keels M., Kibrite A., Morales A., Char D. H., Oldham R. K. Specificity of delayed cutaneous hypersensitivity reactions to extracts of human tumor cells. J Natl Cancer Inst. 1978 Feb;60(2):255–263. doi: 10.1093/jnci/60.2.255. [DOI] [PubMed] [Google Scholar]
  25. Weiland F., Straub O. C. Differences in the in vitro response of lymphocytes from leukotic and normal cattle to concanavalin A. Res Vet Sci. 1976 May;20(3):340–341. [PubMed] [Google Scholar]
  26. al-Sarraf M., Sardesai S., Vaitkevicius V. K. Clinical immunologic responsiveness in malignant disease. II. In vitro lymphocyte response to phytohemagglutinin and the effect of cytotoxic drugs. Oncology. 1972;26(4):357–368. doi: 10.1159/000224687. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Journal of Comparative Medicine are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES